Primary study · included by 1 review

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.

Dai 2016 · Dai Xiaoyu, Fang Xiangming, Ma Ying, et al. · Medicine · 2016

Included by

Bladder cancer risk factors: a comprehensive umbrella review of meta-analyses.

Non-Cochrane · aetiology · 2026 · cited as Dai 2016 · Table 1 (Included MA); References

Outcome this study informs	Pooled effect	Evidence	Certainty
Risk of bladder cancer in men With Benign prostatic hyperplasia vs Without Benign prostatic hyperplasia	RR 1.71	NR	GRADE not reported
Risk of bladder cancer in men With Benign prostatic hyperplasia vs Without Benign prostatic hyperplasia	RR 2.18	NR	GRADE not reported
Risk of bladder cancer in men With Benign prostatic hyperplasia vs Without Benign prostatic hyperplasia	RR 1.75 [1.38, 2.22]	NR	GRADE not reported
Risk of bladder cancer in men With Benign prostatic hyperplasia vs Without Benign prostatic hyperplasia	RR 1.51	NR	GRADE not reported
Risk of bladder cancer in men With Benign prostatic hyperplasia vs Without Benign prostatic hyperplasia	RR 1.95	NR	GRADE not reported
Risk of bladder cancer in men With Benign prostatic hyperplasia vs Without Benign prostatic hyperplasia	RR 1.71 [1.39, 2.11]	6 studies · 629896 participants	Low
Risk of bladder cancer With urinary tract infection vs Without urinary tract infection	RR 1.33 [1.14, 1.55]	8 studies · 29837 participants	Very low
Risk of bladder cancer in men With Benign prostatic hyperplasia vs Without Benign prostatic hyperplasia	RR 2.50	NR	GRADE not reported
Risk of bladder cancer in men With Benign prostatic hyperplasia vs Without Benign prostatic hyperplasia	RR 1.58	NR	GRADE not reported

1 including review in total.